Annals of Epidemiology
Volume 20, Issue 12 , Pages 890-897 , December 2010

Nicotine Dependence Predicts Repeated Use of Prescribed Opioids. Prospective Population-based Cohort Study

  • Svetlana Skurtveit, PhD

      Affiliations

    • Department of Pharmacoepidemiology, Norwegian Institute of Public Health
    • Norwegian Centre for Addiction Research, University of Oslo
    • Corresponding Author InformationAddress correspondence to: Svetlana Skurtveit, PhD, Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, 0403 Oslo, Norway. Tel: +47 23408172. Fax: +47 23408146.
    • ,
  • Kari Furu, PhD

      Affiliations

    • Department of Pharmacoepidemiology, Norwegian Institute of Public Health
    • ,
  • Randi Selmer, PhD

      Affiliations

    • Department of Pharmacoepidemiology, Norwegian Institute of Public Health
    • ,
  • Marte Handal, PhD

      Affiliations

    • Department of Pharmacoepidemiology, Norwegian Institute of Public Health
    • ,
  • Aage Tverdal, PhD

      Affiliations

    • Department of Pharmacoepidemiology, Norwegian Institute of Public Health

Received 9 November 2009 ,Accepted 3 March 2010.

References 

  1. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130
  2. Collins A, Simpson K. Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. The British Pain Society; 2004;9. Available at: http://www.britishpainsociety.org/opioids_doc_2004.pdf. Accessed February 10, 2009.
  3. Kalso E, Allan L, Dellemijn PL, Faura CC, Ilias WK, Jensen TS, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003;7:381–386
  4. Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007;11:490–518
  5. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;3:287–293
  6. McLellan AT, Turner B. Prescription opioids, overdose deaths, and physician responsibility. JAMA. 2008;300:2672–2673
  7. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24:497–508
  8. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004;28:176–188
  9. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710–1714
  10. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087–2093
  11. Simoni-Wastila L. Increases in opioid medication use: balancing the good with the bad. Pain. 2008;138:245–246
  12. Goldberg MS, Scott SC, Mayo NE. A review of the association between cigarette smoking and the development of nonspecific back pain and related outcomes. Spine. 2000;25:995–1014
  13. Warner DO. Perioperative abstinence from cigarettes: physiologic and clinical consequences. Anesthesiology. 2006;104:356–367
  14. Zarrindast MR, Khoshayand MR, Shafaghi B. The development of cross-tolerance between morphine and nicotine in mice. Eur Neuropsychopharmacol. 1999;9:227–233
  15. Biala G, Weglinska B. Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. J Pharm Pharmacol. 2004;56:1021–1028
  16. Shippenberg TS, Heidbreder C, Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol. 1996;299:33–39
  17. Vihavainen T, Piltonen M, Tuominen RK, Korpi ER, Ahtee L. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure. Eur J Pharmacol. 2008;587:169–174
  18. Spiga R, Schmitz J, Day J. Effects of nicotine on methadone self-administration in humans. Drug Alcohol Depend. 1998;50:157–165
  19. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14:315–320
  20. Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med. 2006;144:381–389
  21. Ekholm O, Gronbaek M, Peuckmann V, Sjogren P. Alcohol and smoking behavior in chronic pain patients: The role of opioids. Eur J Pain. 2009;13:606–612
  22. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004;28:250–258
  23. Norwegian Health Surveys. Norwegian Institute of Public Health. Available at: http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5895:0:15,4225:1:0:0:::0:0. Accessed February 10, 2009.
  24. Naess O, Sogaard AJ, Arnesen E, Beckstrom AC, Bjertness E, Engeland A, et al. Cohort profile: cohort of Norway (CONOR). Int J Epidemiol. 2008;37:481–485
  25. Skurtveit S, Furu K, Bramness JG, Tverdal A. Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later–a follow-up study of 13,390 men and women aged 40-42 years. Pharmacoepidemiol Drug Saf. 2008;17:926–933
  26. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95–103
  27. Søgaard AJ, Bjelland I, Tell GS, Røysamb E. A comparison of the CONOR Mental Health Index to the HSCL-10 and HADS. Nor J Epidemiol. 2003;13:279–284
  28. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol. 2008;2:129–136
  29. WHO Collaboration Centre for Drug Statistics Methodology. ATC classification index with DDDs 2007. Norwegian Institute of Public Health. 2006;
  30. Bachs L, Engeland A, Morland J, Skurtveit S. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther. 2009;85:596–599
  31. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007;129:235–255
  32. Cicero TJ, Lynskey M, Todorov A, Inciardi JA, Surratt HL. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain. 2008;139:127–135
  33. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L. Opioid dosing trends and mortality in Washington State workers' compensation, 1996–2002. Am J Ind Med. 2005;48:91–99
  34. Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008;103:258–268
  35. Stover BD, Turner JA, Franklin G, Gluck JV, Fulton-Kehoe D, Sheppard L, et al. Factors associated with early opioid prescription among workers with low back injuries. J Pain. 2006;7:718–725
  36. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172–179
  37. Pedersen W, von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction. 2009;104:129–137
  38. Welcome to the Norwegian Prescription Database. Norwegian Institute of Public Health. Available at: http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5903:0:15,4440:1:0:0:::0:0. Accessed February 10, 2009.
  39. Fredheim OMS, Skurtveit S, Moroz A, Breivik H, Borchgrevink PC. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database. Acta Anaesthesiol Scand. 2009;53:627–633
  40. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18:247–291
  41. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl). 1992;107:285–289
  42. Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther. 1993;265:53–59
  43. Vihavainen T, Relander TR, Leiviska R, Airavaara M, Tuominen RK, Ahtee L, et al. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA. J Neurochem. 2008;107:844–854
  44. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483–488
  45. Warner DO. Tobacco dependence in surgical patients. Curr Opin Anaesthesiol. 2007;20:279–283
  46. Benowitz NL. Nicotine and postoperative management of pain. Anesth Analg. 2008;107:739–741
  47. Flood P, Daniel D. Intranasal nicotine for postoperative pain treatment. Anesthesiology. 2004;101:1417–1421
  48. Habib AS, White WD, El Gasim MA, Saleh G, Polascik TJ, Moul JW, et al. Transdermal nicotine for analgesia after radical retropubic prostatectomy. Anesth Analg. 2008;107:999–1004
  49. Hong D, Conell-Price J, Cheng S, Flood P. Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study. Anesth Analg. 2008;107:1005–1010
  50. Biala G, Weglinska B. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: Involvement of calcium channels. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:15–21
  51. Fleming R, Leventhal H, Glynn K, Ershler J. The role of cigarettes in the initiation and progression of early substance use. Addict Behav. 1989;14:261–272
  52. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol. 1992;53:447–457
  53. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380

PII: S1047-2797(10)00055-4

doi: 10.1016/j.annepidem.2010.03.010

Annals of Epidemiology
Volume 20, Issue 12 , Pages 890-897 , December 2010

Article Tools